FDA reorganizing commissioner’s office

FDA Commissioner Scott Gottlieb plans to reorganize the Office of the Commissioner, creating a flatter structure that gives more power to directors of the agency’s centers.

"This is an effort to elevate the roles of the centers in policy making," Gottlieb told BioCentury.

Gottlieb said he has been meeting weekly with

Read the full 490 word article

User Sign In